BioCentury | Sep 29, 2020
Financial News
Sept. 28 Quick Takes: Biogen gains $1.4B on aducanumab update; plus Zai, XtalPi, InventisBio, Galecto, Innovent, Galapagos-Gilead, Biocytogen and ACT Accelerator
...Foundation —with Abbott Laboratories (NYSE:ABT) and SD Biosensor Inc....
